Hiraide, Sakura
Komine, Keigo
Takahashi, Masanobu
Ishioka, Chikashi http://orcid.org/0000-0002-3023-1227
Article History
Received: 30 November 2020
Accepted: 12 January 2021
First Online: 6 February 2021
Compliance with ethical standards
:
: Chikashi Ishioka received research funding from the Tokyo Cooperative Oncology Group. Chikashi Ishioka received contributions from Chugai Pharmaceutical, Asahi Kasei Pharma Corporation, Ono pharmaceutical, MSD, Pfizer, AstraZeneca, Bristol-Myers Squibb, Janssen Pharmaceutical, Taiho Pharmaceutical, Eisai Pharmaceutical, Daiichi Sankyo Company, Limited, and Takeda Pharmaceutical. Masanobu Takahashi has received research funding from Ono Pharmaceutical Company. Chikashi Ishioka is a representative of Tohoku Clinical Oncology Research and Education Society, a specified non-profit corporation.